A study of health data from over 4 million people finds cannabis users are four times more likely to develop type 2 diabetes, contradicting previous research. This story first appeared on leafie, view here Author: Kevin Dinneen
New research suggests expanding NHS access to medical cannabis could reduce hospital admissions by 28% for eligible patients, whilst adding billions to the UK economy over the next decade. This story first appeared on leafie, view here Author: Liam O'Dowd
New research suggests Germany's CanG act has successfully shifted the market away from illegal dealers, with 88.6% of users acquiring cannabis from legal sources in the past six months. This story first appeared on leafie, view here Author: Kevin Dinneen
New research indicates that cannabis could serve as a substitute for alcohol, with participants drinking 25 percent fewer alcoholic beverages after using cannabis compared to alcohol alone. This story first appeared on leafie, view here Author: Liam O'Dowd
The politician, who was the driving force behind the 2022 decriminalisation of cannabis in Thailand, received royal endorsement on Sunday to become the country's third prime minister in two years. This story first appeared on leafie, view here Author: Kevin Dinneen
Two new studies, one a large meta-analysis and the other real-world evidence from the UK, suggest that cannabis-based medicines, particularly those containing THC or mixed cannabinoids, may improve sleep quality and ease symptoms of insomnia. A new systematic review and meta-analysis, published in the journal Sleep [...]
An 18-month study has found that cannabis-based medicinal products significantly improved sleep quality, reduced anxiety, and enhanced quality of life for insomnia patients, with minimal side effects. This story first appeared on leafie, view here Author: Liam O'Dowd
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval process. Yesterday, the Food Standards Agency (FSA) announced that its 12-week public consultation to discuss the [...]
The country has opened a public consultation on a draft cannabis law, which could come into place before summer 2026. This story first appeared on leafie, view here Author: Kevin Dinneen
Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, the device offers patients a precise, discreet, and clinically approved way to inhale cannabis-based treatments. Since [...]
A study has cast doubt on the widely cited claim that antidepressant drugs such as SSRIs have few withdrawal symptoms, revealing that pharmaceutical industry funding could be skewing data to minimise adverse effects. This story first appeared on leafie, view here Author: Liam O'Dowd
Cannabis Health will host its first expert-led educational event for healthcare professionals later this year, with a focus on bridging the gap between policy and patient access. The one-day, CPD-accredited Cannabis Health Symposium, taking place at Conway Hall in London on Tuesday 25 November, 2025, is [...]
Despite a slow start in facilitating patient access to medical cannabis treatments, this is gradually changing for the better. The UK now has an active patient base of approximately 50,000-60,000, and an estimated 80,000 individuals are expected to receive treatment with CBPMs throughout 2025. The CQC [...]
Cannabis isn’t the “gateway drug” many opponents have labelled it; it’s a plant that leads people into growing their own fruits and vegetables at home. This story first appeared on leafie, view here Author: Kevin Dinneen
Scientists in South Africa say they have found the first evidence of a rare class of phenolics, called ‘flavoalkaloids’, in leaves from the cannabis plant. Phenolic compounds, especially flavonoids, are well-known and sought after in the pharmaceutical industry because of their antioxidant, anti-inflammatory, and anti-carcinogenic properties. [...]
The Minister for Policing and Crime Prevention, Dame Diana Johnson MP, has agreed to ban HHC and other semi-synthetic cannabinoids following AMCD recommendations, which also recommended that THCa be banned. This story first appeared on leafie, view here Author: Liam O'Dowd
A new review has found ‘consistent evidence’ that cannabis improves sexual function in women, and should be considered as a first-line treatment for patients with female orgasm disorder (FOD). After reviewing findings from 16 peer-reviewed studies, including data from over 8,000 women, researchers have formally recommended [...]
A UK medical cannabis clinic is carrying out investigations after a substantial amount of patients’ information was leaked in a major data breach. In an email sent to patients on Monday 18 August, CB1 Medical confirmed it had identified a ‘data security incident’ when patients’ personal [...]
PatientsCann UK has raised urgent concerns with both the UK and Republic of Ireland (ROI) governments over the risks faced by patients prescribed medicines that are classified as Schedule 1 Controlled Drugs in one jurisdiction but legally prescribed in the other. At present, a prescription issued in the UK, ROI or Crown Dependencies cannot be dispensed across the border if the medicine is considered Schedule 1. More critically, patients cannot lawfully carry these prescribed medicines across the border, even if the crossing is unavoidable in order to travel within their own country. This issue disproportionately affects border communities, where travel across the border is not optional but a daily necessity. For patients in these communities, this creates an impossible situation: return home with their prescribed treatment and risk criminalisation, or forego essential medication. Couriers and healthcare professionals delivering medicines face the same challenge. Practical problems and risks The current situation gives rise to multiple, connected harms: Beyond individual harm, the problem creates wider public-health and administrative issues: increased emergency presentations, greater strain on social care and inequitable access to treatment depending on postcode. What PatientsCann UK is asking for PatientsCann UK has written to the governments of the UK and the Republic of Ireland requesting urgent clarification and guidance, including: The Northern Ireland Office has confirmed that officials are reviewing our letter. PatientsCann UK welcomes this development and will continue to press for clear, rapid action to protect patients who rely on any prescribed medicine. Sal Aziz, Director of PatientsCann UK, said: “Patients should never have to choose between taking their prescribed medicine and risking criminalisation. In practice this is what border communities on the island of Ireland face today. Governments must issue clear operational guidance and protections, urgently, so patients can continue to receive care without fear.” What happens next PatientsCann UK will publish updates as official responses are received. In the meantime, anyone affected by this issue is encouraged to contact PatientsCann UK so we can collate evidence and ensure our representations fully reflect the scale and immediacy of the problem. Please email info@patientscann.org.uk or send us a message on socials (Instagram | X).
The post Border Patients at Risk: PatientsCann Raises Concerns with UK & Ireland first appeared on PatientsCann UK.
Using a unique method of analysis, a team of researchers found a number of rare compounds called flavoalkaloids in cannabis leaves for the first time, suggesting that plant material traditionally discarded during processing could contain valuable compounds for future medical applications. This story first appeared on [...]
A new survey of NHS doctors has highlighted a growing demand for alternative treatment options for complex health issues such as chronic pain and women’s health-related concerns. Out of 500 doctors currently practicing in the NHS, almost half of which were GPs, three quarters said that [...]
Ireland has become the latest jurisdiction to ban the use of the semi-synthetic cannabinoid HHC, with ministers raising concerns related to growing use among young people and risks to mental health. The decision, announced by the Department of Health on 29 July, sees Hexahydrocannabinol (HHC) classified as [...]
Study of over 25,000 people found that people who used cannabis performed better in cognitive tests than non users. This story first appeared on leafie, view here Author: Liam O'Dowd
New research on a large data set of older adults suggests cannabis use may be linked to slower brain ageing and improved cognitive function. The study, which used data collected from 25,000 adults aged between 44 and 81 years, found that those who had consumed cannabis [...]
The Advisory Council on the Misuse of Drugs recommended easing the rules on researching substances such as LSD and MDMA, and the government have responded favourably This story first appeared on leafie, view here Author: Kevin Dinneen
A new study is the first to confirm a link between an invasive fungal infection and a medical cannabis product sold to a patient in the US. A cancer patient, using medical cannabis to manage the side effects of chemotherapy, developed a life-threatening fungal infection after [...]
Just months ago, France’s long battle to establish a permanent generalised medical cannabis framework was on the brink of failure. Despite other major European countries looking to France’s 2019 pilot scheme for inspiration, COVID-19, waning political will, operational hurdles, and the dissolution of the National Assembly [...]
A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with cannabis use disorder (CUD) are more than three times more likely to develop oral cancer within five years compared to those without CUD. In 2022, 17.7 [...]
The Care Quality Commission has raised a number of concerns related to the prescribing of cannabis-based products for medicinal use in the UK, as the latest data reveals further increases in private prescriptions. Earlier this month the independent regulator which is responsible for overseeing health and [...]
Demand for private cannabis prescriptions is expected to double in the next four years as patient numbers in Europe’s 2nd largest medical market continue to rise. This story first appeared on leafie, view here Author: Kevin Dinneen
An international survey of people living with eating disorders has found that cannabis and psychedelics, such as ‘magic mushrooms’ or LSD, were best rated as alleviating symptoms by respondents who self-medicated with the non-prescribed drugs. The worst-rated drugs were alcohol, tobacco, nicotine and cocaine. Meanwhile, prescribed [...]
The European medical cannabis sector is experiencing unprecedented growth, driven by progressive legislation, expanding patient access, and a maturing supply chain, according to a new report. Findings from The European Cannabis Report: 10th Edition, published today (Tuesday 29 July), reflect a decade of immense change across European [...]
Older veterans who smoked weed were found to be less likely to experience adverse cardiovascular events, according to a study which claims to be the largest of its kind. This story first appeared on leafie, view here Author: Kevin Dinneen
Current methods used by police to detect drug driving are not based on science, say the authors of a new paper calling for an overhaul of cannabis impairment testing. As cannabis becomes legal in a growing number of US states, public safety experts have raised concerns [...]
The Loop, the UK’s only dedicated drug testing charity, has launched a £25,000 fundraising campaign to expand its harm reduction services. This story first appeared on leafie, view here Author: Liam O'Dowd
In a special edition of the Business of Cannabis Podcast, we go from ‘anecdote to evidence’ with Dr Anne Katrin Schlag, Head of Research and Interim CEO at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move [...]
Over four years after its slated launch, the NHS Cannabis Patient Registry is set to publish its first data. The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end [...]
By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s medical cannabis sector, building a clinical team isn’t just operational work, it’s mission-critical. With the field [...]
A new clinical trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia. The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National Institute on Aging [...]
New research suggests THC-dominant medicinal cannabis provides sustained relief for patients with clinically significant mental health symptoms. This story first appeared on leafie, view here Author: Liam O'Dowd
The study provides preclinical evidence that psilocybin can extend the life of mice and of cells of lab-grown human tissue, which could lead to it being used as a treatment to improve both quality of life and longevity. This story first appeared on leafie, view here [...]
The support group PatientsCann UK has filed a formal complaint against senior police leaders over comments linking the smell of cannabis with criminality and public fear, stating the comments could put patients at risk. This story first appeared on leafie, view here Author: Kevin Dinneen
It’s natural to have questions when considering a new medication, and for many exploring medical cannabis, a common query is about its effects, particularly the feeling often described as a “high.” While cannabis has a long history of medicinal use globally and became legal for medical [...]
Over the past eight months, Business of Cannabis, Cannabis Health, leafie and CannaReporter have conducted a wide-ranging investigation into Dr Green Digital Key — a high-profile blockchain project positioning itself as a game-changer in global cannabis access. Backed and vocally promoted by a man who styles [...]
A bill allowing adults over 21 to possess up to 100 grams of cannabis and grow three plants has been approved by the country’s Senate, and will now be signed by the president to come into law in January 2026. This story first appeared on leafie, [...]
While achieving seizure freedom remains the primary goal of epilepsy treatment, approximately 30% of patients with drug-resistant epilepsy continue to experience seizures despite trying multiple conventional medications. This story first appeared on leafie, view here Author: Kevin Dinneen
Research from two separate studies has highlighted how promotional packaging and social media content can make cannabis-infused products more appealing to teens, prompting calls for more effective regulations. Bright colours, fruit imagery, and labels like “locally made” or “vegan” when used on packaging for cannabis edibles [...]
While frequently disproven, the gateway drug hypothesis claims that cannabis users will go on to use harder, more dangerous substances such as heroin and methamphetamine. This story first appeared on leafie, view here Author: Liam O'Dowd
Patients have called for Switzerland’s new cannabis laws to address ‘unsatisfactory’ medical access ahead of an upcoming consultation on the draft legislation. As legislators look to make further reforms to Switzerland’s cannabis laws, campaigners are urging them to consider the daily realities of those who rely [...]
In the first controlled clinical trial of CBD in boys with autism, two-thirds of participants showed behavioural improvements with treatment, but there was also a significant placebo effect. Researchers at the Center for Medicinal Cannabis Research at University of California San Diego School of Medicine have [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
